FDA Issues Quality Management System Regulation: Final Rule Amending the Quality System Regulation
January 31, 2024
Dear International Colleague,
To ensure medical devices on the market are safe, effective, and of good quality, the U.S. Food and Drug Administration (FDA) issued the Quality Management System Regulation (QMSR) Final Rule today.
The QMSR rule emphasizes risk management activities and risk-based decision-making and aims to reduce regulatory burdens on device manufacturers and importers by harmonizing domestic and international requirements.
The rule amends the current good manufacturing practice requirements of the Quality System regulation.
“This final rule is the latest action taken by the FDA to promote global harmonization in device regulation to help assure that patients and providers have timely and continued access to safe, effective, and high-quality medical devices both at home and abroad,” said Jeff Shuren, M.D., J.D., director of the FDA's Center for Devices and Radiological Health. “By harmonizing key areas of a medical device manufacturer’s quality management system with the international standard, the FDA can better leverage inspections conducted for other countries, while streamlining actions device manufacturers must take to meet requirements by multiple regulatory authorities.”
Device manufacturers and importers will have two years to modify their Quality Systems to meet the requirements of the QMSR rule by February 2, 2026. Until then, manufacturers are required to comply with the existing Quality System regulation.
Related Information
Quality Management System Regulation: Final Rule Amending the Quality System Regulation – Frequently Asked Questions | FDA
Quality System (QS) Regulation/Medical Device Current Good Manufacturing Practices (CGMP) | FDA
###
|
